Clinical application of CSF biomarkers for Alzheimer's disease: From rationale to ratios

Biomarker testing is recommended for the accurate and timely diagnosis of Alzheimer's disease (AD). Using illustrative case narratives we consider how cerebrospinal fluid (CSF) biomarker tests may be used in different presentations of cognitive impairment to facilitate timely and differential d...

Descripción completa

Detalles Bibliográficos
Autores principales: Bouwman, Femke H., Frisoni, Giovanni B., Johnson, Sterling C., Chen, Xiaochun, Engelborghs, Sebastiaan, Ikeuchi, Takeshi, Paquet, Claire, Ritchie, Craig, Bozeat, Sasha, Quevenco, Frances‐Catherine, Teunissen, Charlotte
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Perspective
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9044123/
https://www.ncbi.nlm.nih.gov/pubmed/35496374
http://dx.doi.org/10.1002/dad2.12314

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9044123/
https://www.ncbi.nlm.nih.gov/pubmed/35496374
http://dx.doi.org/10.1002/dad2.12314

Ejemplares similares